Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
about
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line systemMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaBasigin (CD147), a multifunctional transmembrane glycoprotein with various binding partnersThe mechanics of malaria parasite invasion of the human erythrocyte - towards a reassessment of the host cell contributionThe influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?Paths to a malaria vaccine illuminated by parasite genomicsThe Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria VaccineRevealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytesRecent advances in malaria genomics and epigenomicsPlasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean ChildrenTargeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkBP113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPADisruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.Erythrocyte invasion receptors for Plasmodium falciparum: new and old.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.Quantification of Plasmodium-host protein interactions on intact, unmodified erythrocytes by back-scattering interferometry.Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes.Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion.Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine designBasigin is a druggable target for host-oriented antimalarial interventions.Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in KenyaB cells and antibodies in the defense against Mycobacterium tuberculosis infectionCharacterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1.Recent advances in recombinant protein-based malaria vaccines.Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement.Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan populationProgress and prospects for blood-stage malaria vaccinesMalaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption.Use of small-angle X-ray scattering to resolve intracellular structure changes of Escherichia coli cells induced by antibiotic treatment.ECOD: new developments in the evolutionary classification of domains.One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyThe apicomplexan glideosome and adhesins - Structures and function.Host-parasite interactions that guide red blood cell invasion by malaria parasites.Recombinant modified vaccinia virus Ankara-based malaria vaccines.Red cell receptors as access points for malaria infection.Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.
P2860
Q26700012-14CFE242-5AB5-4E1B-88AA-5F2CF86A7903Q26772878-BBA0E405-E07C-4CD1-B781-A30B5CE3BCF5Q26774710-9F9092E4-F242-4DFD-BD44-784D4775C56BQ26776340-B4B6DE1F-9BF1-4205-8F5B-CE146269A377Q26799240-C94D1102-D639-446A-9A08-0F6BF89A975EQ26853267-A2D50755-F4B9-4AA0-9387-B6FFA2171357Q27300745-B5C412F7-55FD-44DB-B6C2-ABD519775CC1Q27321307-C30E7D8D-F6CC-439D-B460-05C919415FFAQ28069435-2314ED34-955F-42EB-86C8-62BBF37998CDQ28554358-45A40D7B-9A44-459E-AB4F-BB16D40A7A41Q28818744-A51E65D1-78FD-4188-8F7D-A6FB72CA32C2Q30042821-782AB993-CEC3-4BCE-BC95-AD12C0D44E71Q30049152-332D8E76-6CF0-485E-8A72-87F1185D792EQ33842928-C5B54F33-D72C-4ECE-AD34-6996534923FCQ34509612-3313A11B-AC55-48E8-AB4A-11129B94CBEFQ34513240-FE99C239-038D-4F6F-8D41-0733CAFD3127Q34523734-61A2DE36-89FD-483C-AA01-BC4D1B10B315Q35147457-A6B6B129-7BE6-48E1-B89F-9950F8D41F5AQ35167000-337D94F7-CA36-4872-A8A4-A6A6A73D482DQ35736368-A74FCB4B-3EBA-4187-86B5-0CDF2CED9B99Q35887367-79A1B462-86B6-4027-BE3E-BF2132422113Q35894355-75EEAF20-86C9-4957-997E-713E3F52BF29Q36148976-C937970E-16F0-4F74-A1D7-A0B7AD04FA67Q36238031-85658BF4-6BE5-4228-A358-B2F98B6B3A96Q36283289-8602D561-FA4C-42C1-AA1F-D2AE02E1435EQ36394182-C3AB0F10-6EF3-4D1D-AE7C-89D8BD4B10C2Q36483323-0FDDBDB6-13B6-4D11-921F-1F002E17696AQ36875789-2E61D7D4-66DB-4EA9-B03B-370D9FFB8795Q37025030-9B7C184A-E3D5-4B8A-AFC3-5B765073244FQ37462647-520E2331-72BF-4842-87F5-A1B29B96958BQ37478157-281FD9CD-E147-484E-AD69-3389E788A18AQ37556908-28E50BA5-C9EC-4966-A60D-1FABC7A574EFQ37626240-A234C341-6FE5-4F81-B14C-B5AC1639D04EQ37699090-615B4B95-401B-4927-8B2E-E642F8FC9306Q38375594-9B7434AC-FF8D-4276-8E8B-67EF0F7022E7Q38376500-40843256-D2FA-446B-B309-EEB61BAB608DQ38618898-A4512FFB-3CFE-4806-9C4D-E1084664104EQ38696399-9AE0A4A7-14D8-46AA-950B-2DC350D5A8DCQ38718229-1DCB1383-5B10-4D81-BC75-E4188C2FEDC8Q39296506-E1B7C0FB-AF5A-460E-B913-EDF9E73CF2CE
P2860
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Structure of malaria invasion ...... asigin and blocking antibodies
@ast
Structure of malaria invasion ...... asigin and blocking antibodies
@en
Structure of malaria invasion ...... asigin and blocking antibodies
@en-gb
Structure of malaria invasion ...... asigin and blocking antibodies
@nl
type
label
Structure of malaria invasion ...... asigin and blocking antibodies
@ast
Structure of malaria invasion ...... asigin and blocking antibodies
@en
Structure of malaria invasion ...... asigin and blocking antibodies
@en-gb
Structure of malaria invasion ...... asigin and blocking antibodies
@nl
prefLabel
Structure of malaria invasion ...... asigin and blocking antibodies
@ast
Structure of malaria invasion ...... asigin and blocking antibodies
@en
Structure of malaria invasion ...... asigin and blocking antibodies
@en-gb
Structure of malaria invasion ...... asigin and blocking antibodies
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Structure of malaria invasion ...... asigin and blocking antibodies
@en
P2093
Jonathan Bartlett
Joseph J Illingworth
Kathryn A Hjerrild
Rebecca Ashfield
Rebecca E Brown
Stine B Clemmensen
Willem A de Jongh
P2860
P2888
P304
P3181
P356
10.1038/NATURE13715
P407
P577
2014-11-20T00:00:00Z
P5875
P6179
1026501198